Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Bos d 4Canis familiarisHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164081.99020100301, Scala E
1.4 - Respiratory Symptoms, Diagnosed2012ItalyIgE7550.39020120821, Liccardi G
6.2 - General Population (Adults)2012SwedenIgE3710.27020120528, Patelis A
6.3 - General Population (Children)2005ItalyIgE2638.400
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE23479.00020060407, Martorell A
3.1.4 - Source Sensitized (SPT, IgE)2013PolandIgE2129.40020130424, Kaczmarski M
3.2.1 - Source Sensitized (IgE)2012TaiwanIgE19060.00020121008, Chen FM
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1403.57020130111, Ott H
5.3.1 - Source Exposed (Symptoms, IgE)2005United StatesIgE11336.200
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
5.1.1 - Source Exposed (Symptoms)2006ItalyIgE9973.700
5.1.1 - Source Exposed (Symptoms)2006ItalySPT9972.700
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE995.05020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE962.08020120528, Patelis A
5.1.1 - Source Exposed (Symptoms)2006ItalyIgE9167.000
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE862.32520101214, Gadisseur R
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE805.000
5.3.1 - Source Exposed (Symptoms, IgE)1996ArgentinaIgE (IB)806.200
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013PolandIgE7918.80020130424, Kaczmarski M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Austria / Germany / Spain / Italy / FranceIgE7862.80020100923, Hochwallner H
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE762.60020131020, van Rhijn BD
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainIgE6773.13020100412, Ibero M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainSPT6782.90020100412, Ibero M
5.3.1 - Source Exposed (Symptoms, IgE)1999FranceIgE5877.600
5.3.1 - Source Exposed (Symptoms, IgE)1999FranceIgE5872.400
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010ItalyIgE5827.59020100716, DUrbano LE
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE352.86020130605, Simon D
3.2.1 - Source Sensitized (IgE)2013United StatesIgE345.88020130409, Kennedy JL
10.1 - Normal Control2012BelgiumIgE273.70020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
5.1.1 - Source Exposed (Symptoms)2003ItalySPT2466.700
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004ItalyIgE2050.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalyIgE2055.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)2002ItalySPT2070.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsIgE1833.33020080401, Lam HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2003ItalySPT1888.900
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008NetherlandsSPT1850.00020080401, Lam HY
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009PortugalIgE1788.23020090910, Sokolova A
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsIgE1338.46020080401, Lam HY
3.1.4 - Source Sensitized (SPT, IgE)2008NetherlandsSPT1118.18020080401, Lam HY
Developed by
Panservice